GlassScriptPhysician profile
Jean Salem
NPI 1326400938
$13,688.30
in general payments reported to CMS, 2019-2025
25 companies · $2,153 in 2025
The $2,153 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $212 · 2021: $1,059 · 2022: $6,127 · 2023: $661 · 2024: $2,762 · 2025: $2,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,832 · Food and Beverage: $2,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,831.91 |
| Food and Beverage | $2,743.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $4,210.25 | 2022-2025 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $3,339.85 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $2,580.20 | 2022-2025 | Interstim, Signia, Ligasure |
| Medical Device Business Services, INC. | $1,200.98 | 2022 | |
| Stryker Corporation | $619.81 | 2024 | 1788, 1688, Spy-Phi System |
| Thd America, INC. | $508.04 | 2022 | |
| Kci USA, INC. | $230.47 | 2019-2023 | V.A.C. Dermatac, V.A.C. Veraflo, Activ.A.C. |
| Allergan, INC. | $133.22 | 2019 | |
| Cook Medical LLC | $129.70 | 2019-2020 | |
| Apollo Endosurgery US INC | $128.93 | 2023 | Overstitch Endoscopic Suturing System |
| Boston Scientific Corporation | $112.74 | 2022 | |
| Baxter Healthcare | $91.51 | 2022 | |
| Edwards Lifesciences Corporation | $66.98 | 2019-2020 | |
| Ethicon US, LLC | $60.46 | 2023-2024 | Echelon Circular, Echelon; Endopath, Stratafix |
| Novo Nordisk INC | $59.00 | 2023-2024 | Saxenda, Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $55.71 | 2024-2025 | Irrisept |
| Ambu INC. | $24.13 | 2023 | |
| Microline Surgical INC | $22.61 | 2025 | |
| Phathom Pharmaceuticals, INC. | $18.53 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $18.46 | 2019 | |
| Alfasigma USA, INC. | $17.62 | 2020 | |
| Olympus America INC. | $16.87 | 2019 | |
| Solventum Corporation | $16.60 | 2025 | Prevena, V.A.C.Ulta |
| Alexion Pharmaceuticals, INC. | $14.02 | 2022 | |
| Pfizer INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Salem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.